Moreover, cancer patients with high expression of GSTA1-1 in their tumors had better prognoses, and the isoenzyme may serve a protective role against hepatocellular carcinoma by suppressing the AMPK/mTOR-signaling pathway [68]. Here, GSTA1 is linked to hepatocellular carcinoma.